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titer to TGR, SFGR, or STGO, the age range was 19–49 
(median 25) years, and job specialties were infantrymen 
(63.5%), fighting vehicle infantrymen (16.4%), indirect 
fire infantrymen (14.2%), and heavy anti-armor weapons 
infantrymen (5.9%).
These results indicate that many US military person-
nel were exposed to rickettsiae and orientiae before their 
deployment to South Korea (Figure), perhaps because of 
previous deployments around the world or because of ex-
posure to rickettsial agents at home (8–10). However, 206 
(2.2%) of the men became infected with either a typhus 
group (n = 10) or spotted fever group (n = 181) rickettsia or 
a scrub typhus group orientia (n = 15) during their deploy-
ment to South Korea.
More SFGR infections occurred than TGR and STGO 
infections, although the pathogens for the latter infections 
(R. typhi and O. tsutsugamushi) are considered endemic 
to South Korea and are believed to affect the public and 
military health more than SFGR (3). The SFGR infec-
tions might correlate with recent observations of highly 
prevalent rickettsia-infected tick and R. felis–infected flea 
populations seen in South Korea (4,5). No evidence of 
co-infection was found in the men assessed during the 
deployment. These results suggest a risk for rickettsial 
disease, including scrub typhus and especially spotted fe-
ver, among US military personnel stationed in or visiting 
South Korea.
This study was supported by the Armed Forces Health Surveil-
lance Center (Global Emerging Infections Surveillance and 
Response System) work unit #0000188M.0931.001.A0074. 
The views expressed herein are those of the authors and do not 
necessarily reflect the official policy or position of the Depart-
ment of the Navy, Department of Defense, or the US Govern-
ment. Copyright protection for this work is not available under 
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To the Editor: Control of methicillin-resistant Staphy-
lococcus aureus (MRSA) is an international public health 
priority. The Netherlands is among countries in Europe that 
have a low prevalence of MRSA among humans, largely 
because of a national search and destroy policy (1). The 
overall prevalence in long-term care facilities (LTCFs) is 
low (2). However, this policy is challenged by an increase 
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in MRSA S. aureus protein A (spa) t1081, which spe-
cifically affects LTCFs. MRSA with the same spa type is 
endemic to Hong Kong, China, and affects hospitals and 
LTCFs (3–5). This finding prompted us to jointly explore 
epidemiologic and strain-related factors.
The low prevalence of MRSA enables the National In-
stitute for Public Health and the Environment (Bilthoven, the 
Netherlands) to type all first MRSA isolates referred from 
clinical laboratories in the Netherlands. In 2007, spa typing 
replaced pulsed-field gel electrophoresis typing. The annual 
number of referred isolates ranged from 1,570 in 2008 to 
2,439 in 2013, excluding livestock-associated strains. Num-
bers of MRSA spa t1081 isolates were low during 2007–2009 
but increased to 127 isolates in 2011 and 218 isolates in 2013.
The search and destroy policy in the Netherlands re-
quires that detection of MRSA infection is followed by 
screening of neighboring patients and personnel in suc-
cessive circles until no new colonizations are found. Most 
reported t1081 isolates represent colonization. In 2013, 
there were 30 infection isolates, 19 unknown isolates, and 
169 colonization isolates.
Severe illness caused by t1081 is rarely reported, and 
eradication therapy is usually successful. In LTCFs, MRSA 
t1081 was more prevalent, accounting for 27% (65/242) 
and 24% (72/299) of all MRSA isolates from LTCFs in 
2011 and 2013 respectively. LTCF clusters were often 
small, but some became large. The t1081 strain was prob-
ably introduced into Amsterdam and subsequently spread 
eastward (Figure).
We sequenced 5 t1081 isolates, 3 from The Netherlands 
(NL2007, NL2011, and NL2013) and 2 from Hong Kong 
(HK2005 and HK2008), by using whole-genome sequenc-
ing (Illumina, San Diego, CA, USA). Sequence data showed 
the CC45/agr IV-MRSA V type (3,6). A total of 91.39% of 
reads of NL2007 aligned with the published CC45/USA600 
sequence (7); NL2007 was more similar to HK2005 and 
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Figure. Spread of methicillin-
resistant Staphylococcus aureus 
spa t1081 in the Netherlands,  
2007–2013. A) 2007; B) 2009; C) 
2011; D) 2013. Source: National 
Institute for Public Heath and the 
Environment (RIVM).
HK2008 (97.32% and 97.61% identity, respectively). 
NL2011 and NL2013 showed slightly decreasing similar-
ity to HK2005 (96.86% and 96.59% identity, respectively) 
and HK2008 (96.97% and 96.69% identity, respectively). 
Staphylococcal cassette chromosome mec type V sequences 
in our isolates were more closely related to each other than 
to the closest reference sequence (GenBank accession no. 
AB505629), which originated from a CC398 isolate.
Phenotypic resistance to tetracycline and ciprofloxacin 
is common in t1081 and is often combined with gentami-
cin and macrolide resistance. tetK, a gene coding resistance 
to tetracycline that is located on the staphylococcal cassette 
chromosome mec element, was detected in reads of all se-
quenced isolates. The macrolide resistance gene ermC on 
plasmid pKH19 (GenBank accession no. NC_010685.1) was 
detected in HK2008, NL2011, and NL2013. Resistance to 
gentamicin (aacA/aphD genes) was detected in all isolates. 
A recent report on epidemic MRSA strain 15 based on many 
whole-genome sequenced strains highlights antimicrobial 
drug use as an evolutionary driving force (8). The tetK gene 
might benefit t1081 in LTCFs in the Netherlands, in which 
doxycycline is used more frequently than in hospitals (Neth-
Map-MARAN 2014; http://www.swab.nl/nethmap).
None of our isolates was positive for Panton-Valentine 
leukocidin, and all isolates had the collagen-binding adhe-
sion gene. In methicillin-sensitive S. aureus, this gene has 
been associated with carriage (9). The apparent high trans-
missibility of t1081 remains to be explained.
The present t1081 outbreak has elicited a debate on 
the policy in the Netherlands. Some elder-care physicians 
question benefits and costs of this policy for a strain that 
is weakly pathogenic. Residents in whom MRSA carriage 
cannot be eradicated face prolonged measures that some 
physicians say are unethical. Conversely, hospital infec-
tion control professionals emphasize that if MRSA can be 
controlled in hospitals, why not in LTCFs? The search and 
destroy policy in the Netherlands faced a major challenge 
in 2001 (10). Uncontrolled dissemination of MRSA had oc-
curred throughout a large hospital in Rotterdam among pa-
tients and staff, as well as in neighboring institutions. This 
outbreak was eventually controlled (10). The Rotterdam 
area, which is southwest of Amsterdam, has not been af-
fected by the current t1081 outbreak.
Concurrent with this professional debate, a public de-
bate is ongoing on the quality of care in LTCFs. Residents 
have more illnesses than a decade ago because of increas-
ingly stringent admission criteria. Skill levels of personnel 
have not kept pace in several LTCFs, as noted by the Health 
Care Inspectorate. Although virtually all LTCFs are pub-
licly funded, quality differences are substantial. This situa-
tion is no longer acceptable, according to public opinion. A 
link between insufficient skill levels in specific LTCFs and 
spread of MRSA can be inferred.
The latest initiative to control multidrug-resistant or-
ganisms, including MRSA in LTCFs, is included in an ex-
isting program for rapid outbreak reporting and support for 
hospitals by the National Institute for Public Health and 
the Environment. This initiative is expected to begin early 
in 2015 and should facilitate control of MRSA in LTCFs.
This study was supported by grants from the Health and Medical 
Research Fund (formerly Research Fund for the Control of In-
fectious Diseases) of the Food and Health Bureau of the Govern-
ment of the Hong Kong Special Administrative Region.
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